Stand Up To Cancer Funds High-Risk Studies in $9.7M Round | GenomeWeb

NEW YORK (GenomeWeb News) – The cancer research fund-raising organization Stand Up To Cancer (SU2C) said today that its latest funding round of $9.7 million includes several grants to support genetics, genomics, and molecular oncology studies.

The grants give up to $750,000 over three years to young researchers who are engaging in "high-risk/high-reward" studies, and the winners were selected by a scientific advisory committee assembled by the American Association for Cancer Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.